JGC
RXDX

J. Goldman & Co’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

J. Goldman & Co’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-20,301
Closed -$2.18M – 416
2023
Q1 		$2.18M Buy
+20,301
New +$2.18M 0.09% 139
2022
Q4 		– Sell
-19,190
Closed -$1.13M – 398
2022
Q3 		$1.13M Sell
19,190
-20,028
-51% -$1.18M 0.05% 170
2022
Q2 		$1.11M Buy
+39,218
New +$1.11M 0.05% 171